Table 2.
Clinical characteristics of patients with COVID-19 who had diagnostic chest CTPA and differences in clinical features between patients with positive and negative CTPA
| Clinical characteristics | All patients (n=92), N (%) | CTPA negative (n=75), N (%) | CTPA positive (n=17), N (%) | P |
|---|---|---|---|---|
| Sex | ||||
| Female | 16 (17.4) | 13 (81.3) | 3 (18.8) | 0.97 |
| Male | 76 (82.6) | 62 (81.6) | 14 (18.4) | |
| Comorbidities | ||||
| Hypertension | 51 (55.4) | 41 (80.4) | 10 (19.6) | 0.75 |
| Diabetes | 28 (30.4) | 24 (85.7) | 4 (14.3) | 0.49 |
| COPD | 5 (5.4) | 4 (4.3) | 1 (1.1) | 0.92 |
| DVT | 3 (3.3) | 3 (3.3) | – | 0.40 |
| CAD | 3 (3.3) | 3 (3.3) | – | 0.40 |
| Stroke | 2 (2.2) | 2 (2.2) | – | 0.49 |
| Clinical outcomes | ||||
| Mechanical ventilation | 25 (27.2) | 17 (68) | 8 (32) | 0.04 |
| Discharge | 74 (80.4) | 63 (85.1) | 11 (14.9) | 0.07 |
| Death | 18 (19.6) | 12 (66.7) | 6 (33.3) | 0.07 |
| Anticoagulation therapeutic | 17 (18.5) | – | 17 (100) | <0.001 |
| Anticoagulation prophylactic | 75 (81.5) | 75 (100) | – | <0.001 |
CAD, coronary artery disease; COPD, chronic obstructive pulmonary disease; COVID-19, coronavirus disease 2019; CTPA, computed tomography pulmonary angiography; DVT, deep vein thrombosis.